Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Chromophobe Renal Cell Carcinoma With Extensive Retraction Artifact: A Potential Diagnostic Pitfall From Micropapillary Urothelial Carcinoma

AR. Sangoi, K. Pivovarcikova, M. Akgul, SR. Williamson, M. Ulamec, JD. Rogala, P. Martinek, T. Vanecek, O. Hes, R. Alaghehbandan

. 2025 ; 33 (1) : 5-12. [pub] 20240403

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010151

In addition to "classic" and eosinophilic subtype, chromophobe renal cell carcinoma (RCC) is well-known to demonstrate various morphological patterns including adenomatoid, microcystic, pigmented, multicystic, papillary, neuroendocrine-like, and small cell-like, all of which are important to appreciate for accurate diagnosis. Herein, we expand on a unique chromophobe RCC morphology not previously described consisting of tumor cells with extensive stromal retraction, mimicking upper urothelial tract micropapillary carcinoma (MPC). Twelve MPC-like chromophobe RCC nephrectomies were reviewed with clinicopathological features recorded; molecular testing was performed on 7 of 12 tumors. Patients were mostly men (n=10) with a mean age of 65 years. Mean tumor size was 6.4 cm with pathological stage distribution as follows: 4 (33%) T1a, 2 (17%) T1b, 1 (8%) T2b, and 3 (25%) T3a. The extent of MPC-like chromophobe RCC foci ranged from 10% to 40% (mean=26%; there was no correlation between the extent of MPC-like chromophobe RCC foci and tumor stage). Other chromophobe RCC morphological patterns were not identified. When performed, all (100%) tumors depicted prototypic chromophobe RCC staining pattern of KIT positivity/KRT7 positivity. Molecular showed 6 of 7 (86%) with multiple chromosomal losses. Clinically significant mutations were identified in NF1, TP53, FLCN (likely somatic), CHEK2, and ZFHX3 genes. Follow up available in 9 patients showed no evidence of disease (mean=23 months). Although the etiology behind the extensive stromal retraction in our tumors is unknown, this may likely be artifactual in nature. Nonetheless, it is important to include MPC-like chromophobe RCC in the spectrum of "variant" morphologies to avoid diagnostic pitfalls from micropapillary carcinoma.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010151
003      
CZ-PrNML
005      
20250429134641.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/10668969241239678 $2 doi
035    __
$a (PubMed)38567430
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sangoi, Ankur R $u Department of Pathology, Stanford Medical Center, Stanford, CA, USA $1 https://orcid.org/0000000308748964
245    10
$a Chromophobe Renal Cell Carcinoma With Extensive Retraction Artifact: A Potential Diagnostic Pitfall From Micropapillary Urothelial Carcinoma / $c AR. Sangoi, K. Pivovarcikova, M. Akgul, SR. Williamson, M. Ulamec, JD. Rogala, P. Martinek, T. Vanecek, O. Hes, R. Alaghehbandan
520    9_
$a In addition to "classic" and eosinophilic subtype, chromophobe renal cell carcinoma (RCC) is well-known to demonstrate various morphological patterns including adenomatoid, microcystic, pigmented, multicystic, papillary, neuroendocrine-like, and small cell-like, all of which are important to appreciate for accurate diagnosis. Herein, we expand on a unique chromophobe RCC morphology not previously described consisting of tumor cells with extensive stromal retraction, mimicking upper urothelial tract micropapillary carcinoma (MPC). Twelve MPC-like chromophobe RCC nephrectomies were reviewed with clinicopathological features recorded; molecular testing was performed on 7 of 12 tumors. Patients were mostly men (n=10) with a mean age of 65 years. Mean tumor size was 6.4 cm with pathological stage distribution as follows: 4 (33%) T1a, 2 (17%) T1b, 1 (8%) T2b, and 3 (25%) T3a. The extent of MPC-like chromophobe RCC foci ranged from 10% to 40% (mean=26%; there was no correlation between the extent of MPC-like chromophobe RCC foci and tumor stage). Other chromophobe RCC morphological patterns were not identified. When performed, all (100%) tumors depicted prototypic chromophobe RCC staining pattern of KIT positivity/KRT7 positivity. Molecular showed 6 of 7 (86%) with multiple chromosomal losses. Clinically significant mutations were identified in NF1, TP53, FLCN (likely somatic), CHEK2, and ZFHX3 genes. Follow up available in 9 patients showed no evidence of disease (mean=23 months). Although the etiology behind the extensive stromal retraction in our tumors is unknown, this may likely be artifactual in nature. Nonetheless, it is important to include MPC-like chromophobe RCC in the spectrum of "variant" morphologies to avoid diagnostic pitfalls from micropapillary carcinoma.
650    _2
$a lidé $7 D006801
650    12
$a karcinom z renálních buněk $x diagnóza $x patologie $x chirurgie $x genetika $7 D002292
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a senioři $7 D000368
650    12
$a nádory ledvin $x patologie $x diagnóza $x chirurgie $x genetika $7 D007680
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a diferenciální diagnóza $7 D003937
650    12
$a artefakty $7 D016477
650    _2
$a papilární karcinom $x patologie $x diagnóza $x chirurgie $7 D002291
650    _2
$a nádorové biomarkery $x analýza $x genetika $7 D014408
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a karcinom z přechodných buněk $x diagnóza $x patologie $x chirurgie $7 D002295
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pivovarcikova, Kristyna $u Department of Pathology, Charles University Hospital and Medical Facility Plzen, Plzen, Czech Republic
700    1_
$a Akgul, Mahmut $u Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY, USA
700    1_
$a Williamson, Sean R $u Department of Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA $1 https://orcid.org/0000000238981460
700    1_
$a Ulamec, Monica $u Department of Pathology, Sestre Milosrdnice University Hospital Center, Department of Pathology and Scientific Centre of Excellence for Reproductive and Regenerative Medicine, School of Medicine, University of Zagreb, Zagreb, Croatia
700    1_
$a Rogala, Joanna Dominica $u Department of Pathology, Regional Specialist Hospital, Wrocław; Department of Pathology, Public Specialist Hospital, Nowa Sól, Poland
700    1_
$a Martinek, Petr $u Department of Pathology, Charles University Hospital and Medical Facility Plzen, Plzen, Czech Republic
700    1_
$a Vanecek, Tomas $u Department of Pathology, Charles University Hospital and Medical Facility Plzen, Plzen, Czech Republic
700    1_
$a Hes, Ondrej $u Department of Pathology, Charles University Hospital and Medical Facility Plzen, Plzen, Czech Republic
700    1_
$a Alaghehbandan, Reza $u Department of Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA $1 https://orcid.org/0000000267085032
773    0_
$w MED00002376 $t International journal of surgical pathology $x 1940-2465 $g Roč. 33, č. 1 (2025), s. 5-12
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38567430 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134637 $b ABA008
999    __
$a ok $b bmc $g 2311499 $s 1247232
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 33 $c 1 $d 5-12 $e 20240403 $i 1940-2465 $m International journal of surgical pathology $n Int J Surg Pathol $x MED00002376
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...